These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


185 related items for PubMed ID: 17670917

  • 21. Cost and clinical implications of diabetes prevention in an Australian setting: a long-term modeling analysis.
    Palmer AJ, Tucker DM.
    Prim Care Diabetes; 2012 Jul; 6(2):109-21. PubMed ID: 22153888
    [Abstract] [Full Text] [Related]

  • 22. Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement.
    Avenell A, Broom J, Brown TJ, Poobalan A, Aucott L, Stearns SC, Smith WC, Jung RT, Campbell MK, Grant AM.
    Health Technol Assess; 2004 May; 8(21):iii-iv, 1-182. PubMed ID: 15147610
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. The potential of metformin for diabetes prevention.
    Slama G.
    Diabetes Metab; 2003 Sep; 29(4 Pt 2):6S104-11. PubMed ID: 14502107
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Metformin & lifestyle intervention prevent Type 2 diabetes: lifestyle intervention has the greater effect.
    Doggrell SA.
    Expert Opin Pharmacother; 2002 Jul; 3(7):1011-3. PubMed ID: 12084000
    [Abstract] [Full Text] [Related]

  • 31. Non-traditional biomarkers and incident diabetes in the Diabetes Prevention Program: comparative effects of lifestyle and metformin interventions.
    Goldberg RB, Bray GA, Marcovina SM, Mather KJ, Orchard TJ, Perreault L, Temprosa M, Diabetes Prevention Program Research Group.
    Diabetologia; 2019 Jan; 62(1):58-69. PubMed ID: 30334082
    [Abstract] [Full Text] [Related]

  • 32. Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program.
    Ratner R, Goldberg R, Haffner S, Marcovina S, Orchard T, Fowler S, Temprosa M, Diabetes Prevention Program Research Group.
    Diabetes Care; 2005 Apr; 28(4):888-94. PubMed ID: 15793191
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. A pragmatic lifestyle modification programme reduces the incidence of predictors of cardio-metabolic disease and dysglycaemia in a young healthy urban South Asian population: a randomised controlled trial.
    Wijesuriya M, Fountoulakis N, Guess N, Banneheka S, Vasantharajah L, Gulliford M, Viberti G, Gnudi L, Karalliedde J.
    BMC Med; 2017 Aug 30; 15(1):146. PubMed ID: 28851373
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Simulating lifestyle and medical interventions to prevent type-2 diabetes: an economic evaluation for Belgium.
    Vandenberghe D.
    Eur J Health Econ; 2022 Mar 30; 23(2):237-248. PubMed ID: 34390431
    [Abstract] [Full Text] [Related]

  • 37. Effects of lifestyle modification and metformin on atherosclerotic indices among HIV-infected patients with the metabolic syndrome.
    Fitch K, Abbara S, Lee H, Stavrou E, Sacks R, Michel T, Hemphill L, Torriani M, Grinspoon S.
    AIDS; 2012 Mar 13; 26(5):587-97. PubMed ID: 22112605
    [Abstract] [Full Text] [Related]

  • 38. Applying some UK Prospective Diabetes Study results to Switzerland: the cost-effectiveness of intensive glycaemic control with metformin versus conventional control in overweight patients with type-2 diabetes.
    Palmer AJ, Sendi PP, Spinas GA.
    Schweiz Med Wochenschr; 2000 Jul 11; 130(27-28):1034-40. PubMed ID: 10953853
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 10.